Journal article
Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study
- Abstract:
-
Aims: To investigate efficacy and safety of dual therapy with liraglutide and metformin in comparison to glimepiride and metformin, and metformin monotherapy over 2years in patients with type 2 diabetes. Methods: In the 26-week the Liraglutide Effect and Action in Diabetes (LEAD)-2 core trial, patients (n=1091) were randomized (2:2:2:1:2) to liraglutide (0.6, 1.2 or 1.8mg once-daily), placebo or glimepiride; all with metformin. Patients were enrolled if they were 18-80years old with HbA1c 7.0...
Expand abstract
Actions
Authors
Bibliographic Details
- Journal:
- Diabetes, Obesity and Metabolism
- Volume:
- 15
- Issue:
- 3
- Pages:
- 204-212
- Publication date:
- 2013-03-01
- DOI:
- EISSN:
-
1463-1326
- ISSN:
-
1462-8902
- Source identifiers:
-
384720
Item Description
- Pubs id:
-
pubs:384720
- UUID:
-
uuid:6899cafc-c983-4535-acbe-422add498363
- Local pid:
- pubs:384720
- Deposit date:
- 2013-11-16
Terms of use
- Copyright date:
- 2013
If you are the owner of this record, you can report an update to it here: Report update to this record